Chemoradiation phase II trials: re-exploring a world of missed opportunities.

CONCLUSIONS: cCRT phase II trials featured severe limitations, with outdated radiation techniques, insufficient reporting of crucial data and a small number of included patients. This certainly limited the impact of conclusions and hindered the development of successful phase III trials.
PMID: 31074314 [PubMed - as supplied by publisher]

Source: Acta Oncologica - May 9, 2019 Category: Cancer & Oncology Authors: Trone JC, Langrand-Escure J, Ollier E, Jmour O, Ben Mrad M, Nevesny S, Lei Q, Benna M, Yazid D, Guy JB, Vallard A, Magné N Tags: Acta Oncol Source Type: research